Laurence Brugières

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

Isabelle Janoueix‐Lerosey, Delphine Lequin, Laurence Brugières et al. · Nature · 2008 · 892 citations

Medicine, Molecular Genetics, Oncology +12

Revisiting Li-Fraumeni Syndrome From <i>TP53</i> Mutation Carriers

Gaëlle Bougeard, Mariette Renaux‐Petel, Jean‐Michel Flaman et al. · Journal of Clinical Oncology · 2015 · 753 citations

Medicine, Cancer Biology, Oncology +17

Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Paolo G. Casali, Stefan Bielack, N. Abecassis et al. · Annals of Oncology · 2018 · 641 citations · Full text

Medicine, Oncology, Surgery +16

ALK-Positive Lymphoma: A Single Disease With a Broad Spectrum of Morphology

Daniel Benharroch, Zarouhie Meguerian-Bedoyan, Laurence Lamant et al. · Blood · 1998 · 527 citations · Full text

Medicine, Oncology, Pathology +15

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano et al. · Nature · 2011 · 522 citations

Medicine, Genetics, Oncology +14